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Background: This study was undertaken to ascertain whether mortality data in the
cardiac surgical literature mirror data reported in national databases.
Methods: This was a review of articles with 50 or more subjects reporting single-
center mortality data for coronary artery bypass or aortic or mitral valve replace-
ment published in the three major cardiothoracic surgical journals from 1997
through 2000. Mortality data and trends were examined.
Results: One hundred sixty-nine articles were found (coronary artery bypass, n =
119; aortic valve replacement, n = 34; mitral valve replacement, n = 16). Articles
were predominantly case series (N = 95), with smaller numbers of comparative ret-
rospective studies (n = 34), randomized trials (n = 29), and prospective noncom-
parative studies (n = 11). The median mortality figures for these studies were 1.5%
(interquartile range, 0.3%-2.6%) for coronary artery bypass, 3.4% (interquartile
range, 2.0%-5.3%) for aortic valve replacement, and 4.7% (interquartile range,
2.1%-6.9%) for mitral valve replacement. In contrast, the national registry mortal-
ity figures were 2.9%, 4.0%, and 6.0%, respectively, in the United States and 2.6%,
4.5% and 6.3%, respectively, in the United Kingdom. Coronary bypass studies with
samples smaller than 100 patients reported lower mortality figures (median 0%)
than did those with more than 100 patients (1.8%). Exploration with graphical plots
suggested a bias toward reporting and publication of studies with below average
mortality.
Conclusions: Particularly for coronary artery bypass, published data tend to under-
represent the risk of death as seen in most centers. Outcomes and magnitudes of
effects as reported in these research studies may not be replicable to the same degree
in most centers. In particular, extreme caution should be taken in extrapolating
results from studies with fewer than 100 patients to larger surgical populations.
Thirty-day mortality is the most frequently quoted outcome measurefor cardiac surgery. Although 30-day mortality may not be an idealoutcome and does have limitations,1,2 mortality is a robust andreproducible outcome measure that is undeniably important and istherefore universally quoted as a measure of supposed safety of car-diac surgical techniques. This study tests the hypothesis that pub-
lished series are biased toward reporting lower mortality figures than are achieved
in most centers.
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Materials and Methods
We systematically reviewed all issues of three cardiothoracic jour-
nals (Annals of Thoracic Surgery, The Journal of Thoracic and
Cardiovascular Surgery, and European Journal of Cardiothoracic
Surgery) published in 4 consecutive years from 1997 through
2000. All original clinical articles including any reference to coro-
nary artery bypass grafting (CABG), aortic valve replacement
(AVR), or mitral valve replacement (MVR) were selected. Articles
with survivals reported formed the study sample. Mortality
expressed as a percentage is an unstable statistic as the denomina-
tor becomes smaller, so an arbitrary cutoff (n = 50) was decided
on, and articles reporting on smaller numbers of cases were arbi-
trarily excluded. Articles were also excluded if a 30-day mortality
for isolated CABG, isolated AVR, or isolated MVR could not be
reliably ascertained, if the data arose from more than one center,
or if the study cohort represented a selected high-risk group (such
as patients with endocarditis). Review articles, letters, and meta-
analyses were excluded. The remaining articles were assessed by
a single observer (A.A.). Data extracted for each article included
sample size, the subject of study, mortality data for the specified
procedure or procedures, study type (case series, prospective
cohort, case-control, controlled trial), country of research, specific
end point of study, and year or years in which the operations were
performed.
National mortality data for 1998 were obtained from the data-
base of the Society of Thoracic Surgeons for North American data
(http://www.sts.org) and Society of Cardiothoracic Surgeons of
Great Britain and Ireland (http://www.scts.org).
Statistical Analysis
A 95% confidence interval (CI) around the mortality for each pro-
cedure in each article was derived from the following formula: 95%
CI = 1.96 · P(1 – P)/n, where P is the observed mortality. For
zero mortality, the 95% CI was computed according to the method
described by Ghosh.3 Comparisons between the median mortality
figures for subgroups were performed with the Wilcoxon test.
Results
One hundred sixty-nine articles met inclusion criteria—
Annals of Thoracic Surgery, 102; The Journal of Thoracic
and Cardiovascular Surgery, 36; and European Journal of
Cardiothoracic Surgery, 31. Articles were mainly case
series (n = 95, 56%), with the remainder being retrospective
comparative studies (n = 34, 20%), randomized controlled
trials (n = 29, 17%) and nonrandomized prospective studies
(n = 11, 7%). Breakdown by operation was as follows:
CABG, 119; AVR, 34; and MVR, 16. The median mortality
figures for the operation groups are shown in Table 1.
Registry mortality figures are shown for comparison.
Because of small numbers for the AVR and MVR groups,
further analysis was limited to the 119 articles reporting on
CABG.
Mortality figures in the articles on CABG are displayed
graphically in Figure 1. Although 91 studies reported a mor-
tality below 3%, the 95% CIs show how imprecise the
quoted percentage mortality figures are as estimates from
which to generalize. Indeed, ranking based on the upper
95% CI boundary shows that the upper 95% CI boundary
exceeded the national mortality data in more than half of the
TABLE 1. Median and interquartile range of mortality data
from journals
Society of
Literature Interquartile Thoracic Surgeons
Median range National Database UK Registry
CABG 1.5% 0.3%-2.6% 2.9% 2.6%
AVR 3.4% 2.0%-5.3% 4.0% 4.5%
MVR 4.7% 2.1%-7.0% 6.0% 6.3%
Mortality data from North American (Society of Thoracic Surgeons
National Database) and British registries are shown for comparison.
Figure 1. Articles on CABG ranked by mortality. Bars represent
95% CIs.
Figure 2. Articles on CABG ranked by upper 95% CI boundary.
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studies (Figure 2). In only a minority of the articles could
mortality be precisely defined; the width of the 95% CI was
often wide, exceeding 5% in a quarter of articles. There was
no significant association between country of publication,
publication type, or primary end point and the reported mor-
tality. Although randomized trials on average reported a
lower mortality (1.0%) than did other study types, this asso-
ciation was not statistically significant. The reported mortal-
ity was, however, statistically significantly lower for articles
with fewer than 100 subjects than for those with a sample
size of 100 or more patients (Table 2). This is investigated
further in the funnel plot (Figure 3), which shows an uneven
distribution with a paucity of studies reporting mortality fig-
ures in excess of national averages. Notably, of the 26 stud-
ies with a sample size of 100 or fewer patients, only 2
reported mortality figures in excess of the national average.
Discussion
This analysis suggests that reading the articles in the car-
diothoracic literature, particularly for CABG, would lead to
a lower expectation of the risk of death than that observed
on a national or international basis. We also demonstrated
the imprecision surrounding mortality data and showed that
although most articles reported operative mortality data
below registry averages, only in a minority of cases were
these statistically different from registry figures. Several
factors may contribute to our finding: (1) Surgeons may
report on selected patient groups that are not typical of all
patients who undergo the procedure (selection bias). (2)
Surgical teams may selectively report only those aspects of
their practice in which they have average or below average
mortality results (reporting bias). (3) Proponents and enthu-
siasts of a new procedure or modification are unlikely to
publish unless the results look good compared with previ-
ous methods. (4) Publications are from academic and expert
units, who would be expected to have superior results. (5)
Patients enrolled in prospective clinical trials are generally
likely to have better outcomes than patients receiving the
same treatment outside clinical trials.4 (6) Finally, workers
with worse than average results may choose not to report
their results, or journals may be less likely to publish their
data (publication bias).
We believe that selection bias, reporting bias, and publi-
cation bias all play prominent roles in the cardiothoracic lit-
erature. In the 40 of 119 articles on CABG in which the
TABLE 2. Associations between article characteristics and
reported mortality
Mortality (%)
Interquartile P
N Median range value
Country of study
American 46 1.8 0.4-3.2 .48
European 55 1.1 0.3-2.6
Study sample size
<100 26 0 0-1.3 .001
≥100 93 1.8 0.9-3.0
Primary end points of study
Included mortality 63 1.2 0.3-2.4 .42
Did not include mortality 56 1.6 0.4-3.0
Study design
Prospective 36 1.2 0-2.7 .62
Retrospective 83 1.6 0.4-2.6
Figure 3. Funnel plot showing asymmetric relationship between
sample size and odds of mortality compared with Society of
Thoracic Surgeons National Database mortality. In most studies
mortality risk was lower than registry mortality (odds ratio < 1);
this was sometimes substantial and in some studies (predomi-
nantly smaller studies) patients were as much as 10 times less
likely to die than were registry patients.
Figure 4. Upper 95% CI boundaries for articles on CABG reporting
no deaths. For articles with fewer than 100 subjects it cannot be
certain that true risk of mortality is below 3%.
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authors specifically stated that they reported an entire series
without exclusion of any definable high-risk group, the
median mortality was 2.5%, which is more in line with reg-
istry outcomes. In contrast, in the remaining 79 studies,
where patient selection was evident or could not be reliably
excluded, the median mortality was 1.0% (P = .001).
Patient selection is therefore a common factor in many stud-
ies reporting lower than expected mortality figures.
Cardiac surgical publications are predominantly based
on retrospective case series, which makes them more sus-
ceptible to publication bias than are clinical trials.5 The
paucity of small studies that report above average mortality
is a hallmark of publication bias.6,7 Thirty-one articles
(CABG, 26; AVR, 3; and MVR 2) reported zero mortality
figures; 20 of these had fewer than 100 subjects. Of the
remaining 11, patient selection was evident in 9. Despite the
small sample sizes, none of the articles reviewed presented
CIs to alert the reader to imprecision of their estimates. The
danger of drawing conclusions about low risk or safety
from a zero numerator has been well described and quanti-
fied8 and is demonstrated in Figure 4, which shows that for
some articles reporting zero mortality the true mortality risk
could be as high as 7%. We believe that the influence of
small sample size would have been even greater had we not
excluded studies with sample sizes smaller than 50.
These observations have implications for interpretation
and application of cardiothoracic research findings.
Operative mortality remains a critical indicator of quality
because it provides a measure of safety of a technique.
Surgeons looking to adopt new approaches described in the
literature will be guided in part by operative mortality rates.
Because few studies present results for unselected patients,
however, it should not be assumed that results similar to
those published in the literature are reproducible. Although
we recognize that some superior results represent excellent
outcomes in expert units and accept that such studies should
represent a standard to which all units should aspire, the
overall picture presented in the literature is overly opti-
mistic and not reflected in registry data. Although experi-
mental studies are accepted as the most robust form of
clinical evidence, our review of the cardiothoracic literature
found many randomized trials that were based on small
samples, some with fewer than 50 subjects. These included
trials making recommendations on important aspects of
cardiac surgical practice, such as myocardial preservation.
Demonstration of survival advantage of one method relative
to another in routine CABG, however, would require a trial
with thousands of patients.9 Results from small studies
should therefore be interpreted only with full appreciation
of their methodologic limitations.
We cannot propose any solutions that will reverse the
overrepresentation of studies with below average mortality
figures. We believe that this trend will remain and stems
from the professional emphasis placed on publication and
from an understandable reluctance to publish one’s results
if they show above average mortality figures. Although
analyses of data from large registries and multiple centers
have several advantages and may be more representative,
they cannot replace case series, prospective studies, and
clinical trials as the preferred modalities for evaluating new
techniques. Journal editors and peer reviewers can, how-
ever, ensure that if data are potentially misleading this is
made clear and preferably accompanied by some measure
of precision (CI). Although no solutions have been offered,
our observation of disparity between the literature and the
registries at least alerts clinicians to the limitations of pub-
lished data. Caution should particularly be exercised in
interpreting results from studies with fewer than 100 sub-
jects, because selection bias and publication bias are more
likely in these cases.
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Discussion
Dr T. Bruce Ferguson, Jr (New Orleans, La). I appreciate the
invitation to discuss this article and congratulate the authors on a
provocative study.
In their examination of the contemporary cardiac surgical liter-
ature, the authors have raised an important issue in the assessment
of surgical outcomes data. In comparing and benchmarking pub-
lished outcomes data, it is important to evaluate the study design,
the nature of the data set, and the risk adjustment techniques used,
if any, in these analyses. As pointed out by the authors, sample size
can be a major factor affecting results, even in randomized trials.
Study designs may be ranked in terms of validity from prospective
randomized trials, to observational data sets, to single institutional
series; however, many of these single institutional series are
designed to evaluate new technology, or at best one technology
against another.
The unique value of the national data sets such as the Society of
Thoracic Surgeons National Database and the United Kingdom
Registry is that they are large and multicentric and can undergo
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sophisticated risk-adjustment analyses not possible with smaller
data sets. The Society of Thoracic Surgeons National Database cur-
rently consists of 1.65 million patient records collected since 1989.
A recent study of more than 1 million patients undergoing isolated
CABG at 522 sites in the United States and Canada has docu-
mented a 41% decline in relative risk-adjusted operative mortality
during the decade from 1990 to 1999. Importantly, this occurred in
the face of a relative increase in expected operative mortality of
33% during that decade predicted in a time-trend analysis. Without
the multicentric national database structure, this type of analysis is
not possible. Moreover, the infrastructure of these national data-
bases allows information exchange and analysis that can directly
result in cardiothoracic surgical quality improvement.
I have two questions. First, in your review of the literature were
a variety of risk-adjustment techniques found? In particular, what
risk adjustment techniques were used in the larger sample size stud-
ies shown in your Figure 3? Second, did you find a trend in mor-
tality that moved toward these national database benchmarks when
only the larger sample size or risk-adjusted series were analyzed?
Mr Anyanwu. With respect to risk adjustment, we did not take
that into consideration, and we reported all articles as they had
been reported. Most articles were case series and did not in any
way incorporate any form of risk adjustment. Most were evaluat-
ing outcomes of a given technique or were randomized trials com-
paring two techniques, and the mortality data were presented as a
raw outcome with no risk adjustment.
With respect to changes in trends in mortality, if we were to
consider just the largest studies with thousands of patients the
median mortality for those was still below the registry average, at
about 1.4%. I think that part of the reason for this is that most of
these came from large North American or Australian centers and a
European center that are known to have good results. If we were
all to publish our results in tens of thousands of patients, however,
the median mortality would shift toward the national average.
Dr Brian Buxton (Heidelberg, Australia). I enjoyed your arti-
cle, and I wonder whether the problem is even greater than you
have shown us here. I question the accuracy of some national reg-
istries. The reason for raising this issue is that we in Australia had
a reported mortality for coronary bypass surgery of about 2% to
2.5% for the national average. Recently we introduced a national
death index, by which we linked the surgical procedure with
patients’ survival or death in a real fashion. Because most people do
not die after leaving the country, I think that the death registry accu-
rately records the true death rate. I was quite concerned to find that
the surgeon-reported 30-day mortality figures in our society were
only about 50% accurate, that is, quite a few patients were not
known by the surgeon to be dead but were found to be dead when
checked with the national death index. I wonder about the accuracy
of some databases because of their voluntary nature. The only other
index I know that is connected with a death registry is the valve reg-
istry of Ken Taylor in the United Kingdom, and he found the same
thing we did, that only about 50% of the early deaths were recog-
nized by the surgeon. It is worse when you analyze survival data,
because most physicians lose track of their patients with time, and
I found that surgeons only recognized a third of the patient deaths
during a period of 10 years. Would you like to comment?
Mr. Anyanwu. I think if anything that the limitations of the
validity of the registry would mean that the registries actually
underestimate rather than overestimate mortality. As you said,
some deaths go unreported, and so it could be that the true mor-
tality of coronary bypass is not 2.5% but is 3.5%, for example. If
that is the case, then the publication bias is even more exaggerated
than we demonstrated. Without doubt, however, even if we were to
cast aside the issue of the national registry mortality figures and
look just at the data in the literature, there is clear evidence of pub-
lication bias, as shown by the difference in mortality figures
between series of selected patients compared with unselected
series, between small samples and big samples, and looking at the
funnel plot there is an asymmetric distribution that suggests a
wealth of unpublished data that are not being reported.
Dr Jeffrey Gold (Bronx, NY). I compliment you on your excel-
lent presentation. We who practice cardiac surgery in New York
State have had the privilege of reporting our results and of having
them monitored carefully by the state. This includes the use of the
Bureau of Vital Statistics, which tracks every 30-day mortality.
These highly monitored outcome numbers track closely with the
Society of Thoracic Surgeons National Database statistics on coro-
nary and valvular heart disease. This provides a comparison of a
highly audited involuntary system with and that of a voluntary
nonaudited system. It would appear that the trends that were
reported here are indeed consistent with our observations and are
accurate.
